Liver Cancer Stage 4 Doctors Abroad — Page 3

Professor Ozcan Yildiz is a senior medical oncologist at Medipol Mega University Hospital with a decade of documented focus on complex neuroendocrine tumours.

• Specialises in managing advanced-stage cancers of the liver and gastrointestinal system
• Published research on the 10-year outcomes of patients with gastroenteropancreatic tumours
• Expert in identifying paraneoplastic syndromes, helping manage secondary symptoms in late-stage cases
• Provides multidisciplinary care at Turkey's largest private university hospital

Associate Professor Yusuf Acikgoz recently enhanced his expertise at Ohio State University, focusing on the latest immunotherapy protocols for advanced gastrointestinal malignancies.

• Investigated CheckMate-649 trials, which tested new immunotherapy combinations for digestive system cancers
• Holds American Society of Clinical Oncology membership, ensuring access to global treatment standards
• Specialises in medical oncology for managing advanced liver and stomach cancer stages
• Trained at Health Sciences University with specific focus on immuno-oncology education in Vienna

Associate Professor Tahsin Ozatli is a senior medical oncologist at Istinye University Liv Hospital, specialising in advanced gastrointestinal cancers.

• Focuses on systemic therapies for stage 4 liver and digestive system tumours
• Achieved rank of Associate Professor – a senior academic title in Turkish medicine
• Previously served at the Ankara Oncology Clinic, a major national cancer centre
• Specialises in managing complex cases involving breast, lung, and liver malignancies

Education

Ondokuz Mayıs University Faculty of Medicine (1991)

KTÜ Faculty of Medicine Farabi Hospital (Specialization.1998)

Istanbul University Çapa Faculty of Medicine (Laparoscopic Surgery Training, 2002)

Istanbul University Çapa Faculty of Medicine (Laparoscopic Antireflux Surgery Training, 2006)

Istanbul University Cerrahpaşa Faculty of Medicine (General Surgery Clinic Advance Laparoscopic Surgery, Laparoscopic Bariatric Surgery, Morbid Obesity and Oncological Cancer Surgery Training, 2010i)

Associate Professor Nail Paksoy is a European-certified medical oncologist specialising in advanced-stage cancer care at Medipol Bahçelievler University Hospital.

• Holds ESMO Board Certification in Medical Oncology, recognised as the gold standard for oncology expertise in Europe
• Uses Lutetium-177 PRRT – a targeted therapy that delivers radiation directly to tumour cells while sparing healthy tissue
• Actively involved in international clinical trials for immunotherapy and targeted drugs with Roche, Pfizer, and Bayer
• Expert in managing complex drug reactions – completed a specialised fellowship in Allergy and Immunology

Professor Gul Alco is a leading radiation oncologist at Medipol Acibadem District Hospital, specialising in high-precision radiotherapy for advanced malignancies.

• Holds the rank of Professor at Istanbul Medipol University, training the next generation of cancer specialists
• Expert in radiation oncology for complex cases, focused on targeting tumours while protecting healthy liver tissue
• Specialises in precise dose delivery to manage symptoms and control growth in advanced-stage cases
• Member of the Turkish Society for Radiation Oncology with deep expertise in multi-disciplinary cancer care

Associate Professor Babek Tabandeh is a member of the American College of Surgeons and specialises in surgical oncology at Medical Park Göztepe Hospital.

• Brings high-level surgical expertise to the Liver Transplantation Society
• Focuses on minimally invasive oncology surgery for reduced pain and faster recovery
• Serves as a faculty member at Bahçeşehir University School of Medicine
• Published over 40 medical papers on surgical techniques and outcomes
• Member of the Istanbul Surgery Association and Turkish Medical Association

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Specializations

Cancer Surgery

Pancreatic Surgery

Bile Duct Surgery

Bariatric Metabolic Surgery

Oncological Surgery

Breast Surgery

Gastric cancer

Colon cancer

Thyroid Cancer

Obesity Surgery

Diabetes Surgeries

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.